Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis

ClinicalTrials.gov ID: NCT01016262

Public ClinicalTrials.gov record NCT01016262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis

Study identification

NCT ID
NCT01016262
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
119 participants

Conditions and interventions

Interventions

  • MAX-002 Drug
  • Placebo Drug
  • Canasa® Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2009
Primary completion
Jul 30, 2011
Completion
Sep 29, 2011
Last update posted
Aug 27, 2019

2009 – 2011

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Birmingham Gastroenterology Associates P.C. Birmingham Alabama 35209
Digestive Health Specialists of the Southeast Dothan Alabama 36305
Desert Sun Gastroenterology Tucson Arizona 85710
Rocky Mountain Gastroenterology Associates Thornton Colorado 80229
Litchfield County Gastroenterology and Associates Torrington Connecticut 06790
Clinical Research of South Florida Boynton Beach Florida 33426
Center for Gastrointestinal Disorders Hollywood Florida 33021
Gastroenterology Group of Naples Naples Florida 34102
Shafran Gastroenterology Center Winter Park Florida 32789
Digestive Research Associates Newnan Georgia 30263
Advanced Pain Care Clinic Evansville Indiana 47714
Gastrointestinal Associates Jackson Mississippi 39202
Center for Digestive & Liver Diseases Inc. Mexico Missouri 65265
South Jersey Gastroenterology Marlton New Jersey 08053
Synergy First Medical Brooklyn New York 11230
Research Associates of New York (RANY) New York New York 10075
Consultants for Clinical Research Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44195
Memphis Gastroenterology Group Germantown Tennessee 38138
The First Clinic Nashville Tennessee 37203
South Texas Research Alliance Laredo Texas 78041
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01016262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01016262 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →